Analytical Data
-
Gene name
ACP1
- Application
-
Alternative Names
HAAP; Low Molecular Weight Phosphotyrosine Protein Phosphatase; Adipocyte acid phosphatase; Red cell acid phosphatase 1; LMW-PTPase
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9D358
-
Expression Region
Met1~Tyr158
-
Molecular Weight
22kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ACP1, or Acid Phosphatase 1, is an important enzyme involved in various biological processes, including cellular signaling, metabolism, and the regulation of phosphate levels within the cell. The enzyme has been implicated in several physiological and pathological conditions, such as cancer and metabolic disorders. The study of recombinant ACP1 proteins has gained considerable attention due to their potential applications in understanding enzyme function, developing therapeutic agents, and exploring the molecular mechanisms underlying diseases. By producing recombinant ACP1, researchers aim to investigate its kinetics, substrate specificity, and interaction with other biomolecules, which could shed light on its role in metabolism and disease pathways. Furthermore, recombinant ACP1 can serve as a valuable tool for drug development, as it allows for high-throughput screening of potential inhibitors and modulators, paving the way for novel therapeutic strategies. Understanding the structural and functional characteristics of ACP1 through recombinant methodologies can also facilitate the design of targeted interventions in diseases associated with altered phosphatase activity, ultimately contributing to advancements in biomedical research and therapeutic applications.
